Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[PMID: 31356792] PubMed record related to this compound for laboratory literature review
)
It is speculated to engage with cellular communication routes, possibly affecting elements associated with rejuvenation and recuperation
Studies examine how the compound affects the browning of white adipose tissue, the inhibition of adipogenesis (the formation of new fat cells), and the rate of lipid oxidation independently from traditional central nervous system stimulants or appetite-suppression loops
Developed by Metabolic Pharmaceuticals in Australia, AOD-9604 was engineered to retain the fat-reducing properties of intact growth hormone while eliminating the undesirable effects on glucose metabolism, insulin sensitivity, and tissue growth
Treatment-specific consent is required by the GMC and CQC to demonstrate that patients were informed about the exact procedure they received, including its specific ingredients, risks, and limitations
US$ 24.21
US$ 22.02
US$ 28.35
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 20.46
US$ 22.37
